CORC

浏览/检索结果: 共131条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3 期刊论文
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 卷号: 176, 期号: 12
作者:  Qin, Xia;  Hu, Longmiao;  Fu, Jing;  Miao, Zhenyuan;  Li, Zheng-gang
收藏  |  浏览/下载:72/0  |  提交时间:2019/12/05
The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging 期刊论文
ONCOLOGY REPORTS, 2019, 卷号: 41, 期号: 5
作者:  Wang, Shengfei;  Niu, Xiaomin;  Bao, Xiao;  Wang, Qin;  Zhang, Jianping
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/05
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 3
作者:  Xu, Song-Tao;  Xi, Jun-Jie;  Zhong, Wen-Zhao;  Mao, Wei-Min;  Wu, Lin
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis 期刊论文
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 卷号: 34, 期号: 2
作者:  Huang, Ruofan;  Ge, Mengxi;  Zhou, Xinli;  Ji, Xiaoyu;  Liao, Li
收藏  |  浏览/下载:23/0  |  提交时间:2019/12/05
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients 期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13
作者:  Zhang, Tengfei;  Zhang, Lu;  Xie, Yuancai;  Li, Bing;  Ma, Yafeng
收藏  |  浏览/下载:24/0  |  提交时间:2019/12/05
Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells 期刊论文
ANTI-CANCER DRUGS, 2019, 卷号: 30, 期号: 1
作者:  He, Jian;  Qi, Zihao;  Zhang, Xiaofei;  Yang, Yufei;  Liu, Fei
收藏  |  浏览/下载:20/0  |  提交时间:2019/12/05
Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations 期刊论文
MEDICAL SCIENCE MONITOR, 2019, 卷号: 25
作者:  Zhang, Hua-Hui;  Mao, Jian-S.;  Hu, Wei-F.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/05
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:  Yu, Hui;  Sun, Si;  Hu, Xingjiang;  Xia, Jinjing;  Wang, Jialei
收藏  |  浏览/下载:25/0  |  提交时间:2019/12/05
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 2
作者:  Xu, Xiaojing;  Li, Hong;  Peng, Ke;  Yu, Yiyi;  Chen, Lingli
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/05
Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer 期刊论文
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 卷号: 78
作者:  Lu, Ji;  Zhou, Kun;  Yin, Xiaoxing;  Xu, Han;  Ma, Baojin
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace